This item requires a subscription to Diabetes Care.
Full Text (PDF)
Original Research - Cardiovascular and Metabolic Risk:
David Preiss,
Sofia Zetterstrand,
John J.V. McMurray,
Jan Östergren,
Eric L. Michelson,
Christopher B. Granger,
Salim Yusuf,
Karl Swedberg,
Marc A. Pfeffer,
Hertzel C. Gerstein,
Naveed Sattar,
and for the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity Investigators
Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment
of Reduction in Mortality and Morbidity (CHARM) Program Diabetes Care May 2009 32:915-920; published ahead of print February 5, 2009, doi:10.2337/dc08-1709